Gujarat Themis Biosyn Ltd manufactures and sells finished Active Pharmaceutical Ingredients products by fermentation processBusiness Overview Company manufactures pharmaceuticals and medicinal chemicals. It is actively managed by Themis Medicare Ltd. (JV company of Gedeon Richter Ltd, Hungary). GTBL entered into Technical & Financial collaboration with Yuhan Corporation, South Korea, and...
Gujarat Themis Biosyn Limited has approved raising up to INR 585 Cr through the issuance of Non-Convertible Debentures (NCDs) on a private placement basis.
Gujarat Themis Biosyn Limited has informed the Exchange regarding Notice of Annual General Meeting to be held on September 30, 2026
Gujarat Themis Biosyn Limited has informed the Exchange about Copy of Newspaper Publication of 45th AGM notice.
Gujarat Themis Biosyn Limited has informed the Exchange regarding Notice of 45th AGM to be held on September 30, 2026
Gujarat Themis Biosyn's board approved a preferential issue of up to 82.11 lakh equity shares at Rs. 408 each, aiming to raise Rs. 335.00 crore. This capital infusion is subject to shareholder approval.
